IDIX (MM)

Today, www.EquityLeader.com introduced research coverage of Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) and Dollar Tree, Inc. (NASDAQ: DLTR). Full research reports are available to readers at: www.EquityLeader.com/index.php?sm1=IDIX&sm2=DLTR.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Idenix Pharmaceuticals, Inc. for its current position within the healthcare industry. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. The Company's research and development focus is on the treatment of hepatitis C virus (HCV). A copy of this report detailing Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) is available at: www.EquityLeader.com/index.php?sm1=IDIX.

Equity Leader is also taking note of Dollar Tree, Inc. for its changing role within the services industry. Dollar Tree, Inc. is an operator of discount variety stores offering merchandise at the fixed price of $1. At January 29, 2011, the Company operated 4,101 discount variety retail stores. Its stores operate under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant and Dollar Bills. To download free research on Dollar Tree, Inc. (NASDAQ: DLTR) investors may visit: www.EquityLeader.com/index.php?sm2=DLTR.

About Equity Leader Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.

Contact: Michael Westbrook Email Contact www.EquityLeader.com